RGS HEALTHCARE, Orlando, FL (2026)

07/29/2026

There’s one thing you can’t get from a device manual or a webinar: the feel of live tissue response under the probe.

That’s why cadaver training exists — and why it’s the difference between physicians who feel confident offering thyroid RFA and physicians who keep putting it off.

Here’s the problem: opportunities to get that hands-on experience are limited. And this year, they’re about to run out.

October 10, Orlando — the last U.S. cadaver-based thyroid RFA training of 2026. Once this date passes, there’s no other U.S. training on the calendar until next year.

If you’re an ENT, endocrinologist, interventional radiologist, or surgeon who’s been meaning to get certified — or you’re evaluating whether RFA belongs in your practice — this is the window. Not a future one.

Seats are limited and this is the final call for 2026.

Details and registration: rgshealthcare.com

07/27/2026

She’d lived with the lump for three years.

Not because she didn’t notice it. She noticed it every time she looked in the mirror, every time she buttoned a collared shirt, every time someone glanced a beat too long at her neck.

Her endocrinologist called it benign. Small. Stable. “Nothing to worry about.”

But nothing to worry about medically isn’t the same as nothing to live with.

She asked about surgery once. The word that came back was “thyroidectomy” — and with it, a lifetime of hormone replacement for a nodule that wasn’t even cancer. She decided the lump was easier to live with than that trade-off.

Then her doctor mentioned an option she’d never heard of: radiofrequency ablation. No incision. No general anesthesia. No hospital stay. Just a needle, ultrasound guidance, and a same-day recovery.

Three months later, the nodule had shrunk by more than half. Her neck was smooth. Her thyroid — the one she’d been told she’d have to give up — was still hers, still working.

This is the story we hear more often than people expect. Patients don’t come to RFA because it’s cutting-edge. They come because the old choice — watch and wait, or lose the gland entirely — never felt like a real choice at all.

For physicians, that’s the opening. A treatment option that meets patients exactly where their hesitation lives.

Learn more at rgshealthcare.com

07/27/2026

Most practices don’t realize how much their ultrasound platform is costing them until they compare workflows side by side.

Slower exam times. Grainy imaging on deep or complex anatomy. Probes that don’t match the case mix your practice actually sees. It adds up in ways that don’t show up on a single invoice, but do show up in your schedule.

RGS Healthcare works with practices across specialties, ENT, endocrinology, vascular, urology, OB/GYN, and general surgery, to match ultrasound systems to how they actually practice, not just what’s in a catalog. Our lineup includes:

- Alpinion X-Cube i9 and E-Cube i7 for high-acuity, image-critical exams
- MiniSono for compact, point-of-care flexibility
- XCube 70/90 for practices that need dependable, everyday performance

The right system isn’t the one with the most features. It’s the one that fits your patient volume, your exam types, and your team’s workflow.

If your current ultrasound setup is slowing you down or holding back image quality, it’s worth a conversation.

Learn more at rgshealthcare.com

$A patient comes in hunched over, in pain, barely able to stand up straight. X-ray shows a vertebral compression fracture...$

07/25/2026

A patient comes in hunched over, in pain, barely able to stand up straight. X-ray shows a vertebral compression fracture. The old playbook: bed rest, pain meds, and wait it out for weeks — sometimes months.

Kyphoplasty changes that timeline.

It’s a minimally invasive procedure — a balloon creates a cavity in the fractured vertebra, which is then filled with bone cement to restore height and stability. Many patients report significant pain relief within 24-48 hours, not weeks.

For physicians treating osteoporotic and pathologic compression fractures, this isn’t just a procedure — it’s giving patients their mobility and independence back faster.

Learn more about RGS Healthcare’s kyphoplasty solutions at rgshealthcare.com

07/24/2026

Patients are asking for thyroid RFA by name now.

If your practice can’t offer it, you’re not losing the conversation — you’re losing the patient. They’re finding a provider down the street who can.

Here’s what’s changing fast:

→ Thyroid RFA moved to Category I CPT codes (60660, +60661) effective January 2025, with Medicare-assigned RVUs. This is no longer a fringe procedure — it’s an established part of the reimbursement landscape.

→ Referring physicians are actively looking for RFA-trained specialists to send patients to. Whoever builds that relationship first tends to keep it.

→ Patients with symptomatic nodules increasingly want an alternative to surgery. When they can’t get it from you, they go elsewhere — and so does every patient they refer afterward.

The providers who trained early aren’t scrambling to catch up. They’re the ones other physicians in their region already call first.

Our October 10 Orlando cadaver training is the final U.S. training date in 2026. After that, the next opportunity isn’t until next year — and the referral relationships in your area will already be forming without you.

Learn more at rgshealthcare.com

07/23/2026

Most procedural complications don’t come down to the physician’s hands.

They come down to what the physician could actually see.

Vascular structures. Tissue planes. Needle tip position in real time, in tissue that doesn’t always cooperate. Whether a mass is what you think it is before you commit to a plan.

That’s true in thyroid and soft tissue work. It’s true in vascular access. It’s true in MSK, in general and abdominal imaging, in OB/GYN, in point-of-care exams where a fast, clear answer changes what happens next.

A good ultrasound system isn’t an accessory to good care. It’s the foundation of it.

Resolution that separates healthy tissue from pathology instead of leaving it to guesswork. Frame rates that keep up with a moving needle instead of lagging behind it. Doppler that flags a vessel before it becomes a problem instead of after.

Physicians who’ve upgraded from an aging or general-purpose system tend to describe the same thing: more confidence in what they’re seeing, fewer surprises mid-procedure, and less time spent working around the machine’s limitations.

The RGS ultrasound lineup - including the Alpinion X-Cube i9, E-Cube i7, MiniSono, SonoCine Awbus, and XCube 70/90 - covers a range of specialties and settings, from focused point-of-care use to full-featured imaging for complex procedural work.

If your current system is making you work harder than it should, that’s worth a second look.

rgshealthcare.com

07/18/2026

There’s no substitute for hands-on experience.

Yesterday’s Thyroid RFA Cadaver Training in Boston brought physicians together for a full day of education, starting with in-depth didactic sessions on RFA theory and technique before moving into immersive, hands-on cadaver work focused on developing real procedural confidence—not just learning the technique, but performing it.

Under the instruction of Dr. Ralph Tufano and Dr. David Goldenberg, participants worked with cadaver tissue using the Mygen™ V-1000, refining essential skills including ultrasound-guided probe positioning, energy delivery, margin control, and the clinical decision-making that comes with every case.

While lectures and videos provide the foundation, confidence is built through repetition and guided experience. Performing the moving-shot technique under expert supervision gives physicians the opportunity to develop the skills needed before bringing thyroid RFA into clinical practice.

Thank you to everyone who joined us in Boston for an outstanding day of education and collaboration.

Our final U.S. Thyroid RFA Cadaver Training of 2026 will take place on October 10 in Orlando, Florida. With intentionally small training groups to maximize hands-on instruction, space is limited.

If you’d like to register or learn more about our upcoming training, visit https://thyroidrfatraining.com/hands-on-training/cadaver-workshop/ or call 866-791-0716.

07/15/2026

Your patient gets one dose per case. Your tech gets one every single day.

Cumulative radiation exposure for staff standing at the table isn’t a footnote — it’s an occupational reality that adds up over a career, especially in high-volume fluoroscopic rooms.

Older or underpowered C-arm systems often mean more time in beam, more repositioning, more exposure than the case actually requires.

The Extron 3 Omni and Extron 5 Premium were built with dose efficiency as a core design factor, not an afterthought — imaging that gets it right without asking your team to absorb the cost.

👉 See both systems at rgshealthcare.com

07/08/2026

For years, benign thyroid nodules left providers with two options: watch and wait, or refer out for surgery.

There’s a third option a lot of providers still don’t fully understand: Thyroid Radiofrequency Ablation (RFA).

Here’s what it actually is.

Thyroid RFA is a minimally invasive, image-guided procedure that uses controlled heat to shrink benign thyroid nodules — without an incision, without general anesthesia, and without removing the thyroid gland

Under real-time ultrasound guidance, a thin electrode is inserted directly into the nodule. Using the “moving shot” technique, the physician methodically ablates the tissue in small units, causing the nodule to break down and shrink over time — while preserving healthy surrounding thyroid tissue.

Patients typically go home the same day. Most return to normal activity within 24 hours.

The clinical results speak for themselves: published outcomes data shows nodule volume reduction averaging over 80% at 12 months, with therapeutic success rates near 98%.

For providers, RFA fills a real gap — a treatment option for symptomatic or cosmetically concerning nodules that don’t meet the threshold for surgery, but are past the point of “just keep watching it.”

RFA isn’t replacing surgery. It’s giving providers an option that didn’t exist before.

If you’re an endocrinologist, ENT, or interventional radiologist and this is new territory, we’re happy to talk through where it fits into your practice.

07/07/2026

Most benign thyroid nodule patients are told there are only two options: watch it, or cut it out.

A prospective multicenter study tracking 276 patients treated with radiofrequency ablation found mean nodule volume reduction of 80.3% at 12 months, climbing to 95.3% by 5 years, with a 97.8% therapeutic success rate and major complications in just 1.0% of cases.

That’s a third option — one that treats the nodule without a scar, without general anesthesia, and without an OR.

If you’re an IR, endocrinologist, ENT, or surgeon ready to bring RFA into your practice, our July 17th hands-on cadaver workshop in Boston is the place to start. You’ll train directly under Dr. Ralph Tufano and Dr. David Goldenberg.

Details and registration: https://thyroidrfatraining.com/hands-on-training/

Source: Jung SL, Baek JH, Lee JH, et al. “Efficacy and Safety of Radiofrequency Ablation for Benign Thyroid Nodules: A Prospective Multicenter Study.” Korean J Radiol. 2018;19(1):167-174.

RGS HEALTHCARE

07/29/2026

07/27/2026

07/27/2026

07/25/2026

07/24/2026

07/23/2026

07/18/2026

07/15/2026

07/08/2026

07/07/2026

Address

Website

Alerts

Contact The Practice

Shortcuts

Share

Category